Article
An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates.
Cytopathology : official journal of the British Society for Clinical Cytology - 1 May 2022
Agrawal Tanupriya, Xi Liqiang, Navarro Winnifred, Raffeld Mark, Patel Snehal B, Roth Mark J, Klubo-Gwiezdzinska Joanna, Filie Armando C
Abstract excerpt
INTRODUCTION: Molecular testing for genetic alterations in thyroid neoplasms, including BRAF V600E (BRAF) mutation, are often applied to thyroid aspirates falling into the Bethesda System for Reporting Thyroid Cytopathology indeterminate categories. Current methods typically use dedicated aspirated material, without morphological determination of containing the cells of interest and may be of elevated cost. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.